Here we report unprecedented high plasma insulin and C-peptide responses (elicited by iv infusion of GLP-1 during hyperglycaemia) in a healthy subject, and propose potential mechanistic differences underlying the differential insulinotropic effects of the two incretins. The gene discussed is INS; the disease is Hyperglycemia.